Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST004086)

HILIC NEGATIVE ION MODE (Analysis AN006773)

Metabolite	Structure	F1	F2	F3	F4	F5
19-HETE	ME1084936	1.13	1.02	0.71	1.16	0.94
PGJ2	ME1084919	1.37	0.83	0.44	0.90	0.98
8,9 DHET	ME1084939	1.15	0.99	1.32	0.83	0.85
14,15 DHET	ME1084932	1.16	0.88	1.28	0.76	1.03
5,6 DHET	ME1084937	1.19	0.93	1.21	0.81	0.95
TXB3	ME1084956	0.66	1.02	0.96	1.29	1.06
14,15-DiHETE	ME1084963	0.90	0.97	0.91	1.05	1.12
5,6-DiHETE	ME1084968	0.89	0.98	0.81	0.99	1.25
17,18-DiHETE	ME1084965	0.98	1.01	1.03	0.85	1.14
18-HETE	ME1084935	0.93	1.08	1.00	0.99	1.01
11,12 DHET	ME1084930	0.87	1.09	1.29	0.99	0.89
12,13 diHOME	ME1084974	0.82	1.26	1.10	0.92	0.95
9,10 diHOME	ME1084976	0.82	1.27	1.01	1.03	0.88
12,13 EpOME	ME1084975	0.33	1.75	0.44	1.55	0.68
9,10 EpOME	ME1084977	0.18	1.60	0.51	1.74	0.76
PGD2	ME1084916	0.31	1.17	1.18	1.52	0.89
PGE2	ME1084917	0.35	1.36	1.12	1.45	0.78
17,18-EEQ	ME1084966	0.46	1.39	0.45	1.52	0.94
9-HEPE	ME1084961	0.51	1.14	0.45	1.67	0.99
6k-PGF1a	ME1084915	0.59	1.17	0.71	1.37	1.04
8-HETE	ME1084927	0.48	1.13	0.69	1.54	1.02
18-HEPE	ME1084967	0.23	1.19	0.71	1.52	1.22
11-HEPE	ME1084957	0.24	1.21	0.68	1.60	1.14
11-HETE	ME1084921	0.30	1.18	0.66	1.64	1.07
20-HDoHE	ME1084947	0.23	1.31	0.81	1.49	1.08
19,20-EDP	ME1084953	0.29	1.30	0.78	1.52	1.01
13-HDoHE	ME1084944	0.29	1.29	0.79	1.48	1.07
7-HDoHE	ME1084950	0.31	1.26	0.76	1.48	1.09
15-HEPE	ME1084959	0.27	1.27	0.72	1.53	1.09
5-HEPE	ME1084960	0.31	1.22	0.71	1.54	1.11
10-HDoHE	ME1084942	0.36	1.25	0.74	1.49	1.05
16,17-EDP	ME1084952	0.34	1.30	0.69	1.48	1.05
11-HDoHE	ME1084943	0.26	1.19	0.86	1.55	1.08
17-HDoHE	ME1084946	0.37	1.13	0.81	1.51	1.10
8-HDoHE	ME1084951	0.34	1.22	0.82	1.49	1.05
15-oxo-ETE	ME1084924	0.21	1.41	0.84	1.50	0.97
15-HETE	ME1084923	0.22	1.29	0.85	1.56	1.01
9-HETE	ME1084928	0.23	1.26	0.79	1.64	1.00
4-HDoHE	ME1084948	0.33	1.31	0.96	1.27	1.10
5-oxo-ETE	ME1084926	0.37	1.44	0.92	1.33	0.91
15d-PGJ2	ME1084914	0.36	1.32	0.85	1.46	0.95
16-HETE	ME1084934	0.31	1.33	0.98	1.46	0.91
5-HETE	ME1084925	0.28	1.27	0.96	1.47	1.01
14,15-EET	ME1084933	0.37	1.33	0.69	1.56	0.91
11,12-EET	ME1084931	0.23	1.40	0.65	1.67	0.90
8,9-EET	ME1084940	0.28	1.43	0.68	1.58	0.90
13-oxoODE	ME1084972	0.12	1.48	0.71	1.75	0.82
6R-LXA4	ME1084949	0.13	1.49	0.77	1.72	0.79
5,6-EET	ME1084938	0.19	1.32	0.75	1.74	0.89
13-HODE	ME1084971	0.19	1.42	0.80	1.62	0.88
9-HODE	ME1084973	0.17	1.39	0.76	1.69	0.89
LTB4	ME1084929	0.22	1.14	0.67	1.79	1.03
5,6-EEQ	ME1084969	0.17	1.22	0.51	1.91	0.97
8,9-EEQ	ME1084970	0.24	1.26	0.56	1.72	1.04
11,12-EEQ	ME1084962	0.23	1.35	0.42	1.75	1.00
14,15-EEQ	ME1084964	0.24	1.31	0.48	1.73	1.02
TXB2	ME1084920	0.50	0.85	0.33	1.70	1.32
12-HEPE	ME1084958	0.91	1.08	0.25	1.56	0.88
14-HDoHE	ME1084945	0.95	1.07	0.42	1.43	0.89
12-HETE	ME1084922	0.80	0.97	0.36	1.54	1.06
EPA	ME1084955	0.65	1.13	0.42	1.47	1.08
DHA	ME1084941	0.71	1.45	0.42	1.44	0.72
DPA	ME1084954	0.76	1.49	0.35	1.41	0.71
AA	ME1084913	0.93	1.26	0.57	1.25	0.81
PGF2a	ME1084918	0.80	1.24	0.52	1.38	0.87

Factors:

F1	Sample source:blood \| Treatment:AAC
F2	Sample source:blood \| Treatment:AAC+Ex
F3	Sample source:blood \| Treatment:AAC+Ex+AAV-sEH
F4	Sample source:blood \| Treatment:AAC+TPPU
F5	Sample source:blood \| Treatment:SHAM

Data matrix